The corona pandemic COVID-19 is far from complete, while virus experts and researchers around the world are still struggling to find a vaccine against the SARS-CoV-2 corona virus. In China, two types of corona vaccines were tested on humans recently.
The country’s official press agency revealed that China has now begun clinical trials of two potential vaccines for the corona virus. The vaccine clinical trial is said to have been made by a team at the Wuhan Institute of Biological Products, which is linked to the state-owned China National Pharmaceutical Group, and Sinovac Research and Development Co., Ltd., based in the Chinese capital, Beijing.
According to reports, both trials of the two vaccines have begun. The two vaccine candidates tested were inactive vaccines. That is, it contains virus particles that cannot cause disease, as quoted by Newsweek.
The trial was carried out by the research team by taking a different approach, such as using genetic material from the corona virus, as a basis rather than using inactive particles. While in March, Chinese biopharmaceutical company CanSino Biologics began clinical trials for the COVID-19 Ad5-nCoV vaccine using RNA, or genetic information from the corona virus.
Scientists at the Moderna biotech company also took this approach. In March, their COVID-19 vaccine was the first to be tested on humans, at the Kaiser Permanente Washington Health Research Institute.
So far, according to the draft list of vaccine candidates published by the World Health Organization (WHO) on April 11, 2020, there have been 70 vaccines to prevent COVID-19, which is being developed worldwide.
However, it must be remembered though that experts in the virus, scientists and researchers around the world are working hard to find the corona virus vaccine. Basically, as said by Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), making a vaccine is a relatively long process. The process of finding a vaccine can take at least one year to one and a half years.
Not only vaccines, scientists in the world are also competing to make special treatments for COVID-19 given the positive cases continue to increase.
From data released by Johns Hopkins University, now more than 1.9 million people have been diagnosed with COVID-19 worldwide. With a total of 119,818 people have died and more than 458,000 people have recovered.